Financial reports
10-K
2023 FY
Annual report
22 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
10-K
2022 FY
Annual report
15 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
10 Mar 22
Current reports
8-K
Regulation FD Disclosure
22 Apr 24
8-K
Regulation FD Disclosure
10 Apr 24
8-K
Entry into a Material Definitive Agreement
25 Mar 24
8-K
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
12 Mar 24
8-K
Regulation FD Disclosure
14 Feb 24
8-K
Entry into a Material Definitive Agreement
12 Feb 24
8-K
Other Events
8 Feb 24
8-K
Other Events
8 Feb 24
8-K
Other Events
18 Dec 23
8-K
Other Events
12 Dec 23
Registration and prospectus
S-8
Registration of securities for employees
3 Apr 24
424B5
Prospectus supplement for primary offering
25 Mar 24
424B5
Prospectus supplement for primary offering
8 Feb 24
S-3
Shelf registration
12 Jan 24
424B5
Prospectus supplement for primary offering
14 Nov 23
RW WD
Withdrawal of registration withdrawal request
13 Nov 23
RW
Registration withdrawal request
13 Nov 23
S-3
Shelf registration
2 Nov 23
S-8
Registration of securities for employees
17 Mar 23
S-8
Registration of securities for employees
16 Aug 22
Proxies
PRE 14A
Preliminary proxy
19 Apr 24
DEF 14A
Definitive proxy
17 May 23
DEFA14A
Additional proxy soliciting materials
5 Apr 22
DEF 14A
Definitive proxy
5 Apr 22
DEFA14A
Additional proxy soliciting materials
27 Apr 21
DEF 14A
Definitive proxy
27 Apr 21
PRE 14A
Preliminary proxy
14 Apr 21
DEFA14A
Additional proxy soliciting materials
6 Apr 20
DEF 14A
Definitive proxy
6 Apr 20
DEFA14A
Additional proxy soliciting materials
2 Apr 19
Other
EFFECT
Notice of effectiveness
23 Jan 24
UPLOAD
Letter from SEC
19 Jan 24
CORRESP
Correspondence with SEC
19 Jan 24
EFFECT
Notice of effectiveness
14 Nov 23
CORRESP
Correspondence with SEC
13 Nov 23
CORRESP
Correspondence with SEC
9 Nov 23
UPLOAD
Letter from SEC
3 Nov 23
EFFECT
Notice of effectiveness
17 Jun 22
CORRESP
Correspondence with SEC
14 Jun 22
UPLOAD
Letter from SEC
2 Jun 22
Ownership
4
Vincent O'Neill
8 Apr 24
4
Vimal Mehta
8 Apr 24
4
Richard I Steinhart
8 Apr 24
4
Matthew T. Wiley
8 Apr 24
4
Javier Rodriguez
8 Apr 24
4
Frank Yocca
8 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24